Highly Ranked in the U.S. for Cancer
Recently Added |view more
Pancreatic Cancer: Study Finds Most Early Staging Inaccurate
Staging of patients with early pancreatic cancer is inaccurate as much as 80% of the time, according to a new Cedars-Sinai Cancer study published in the peer-reviewed journal JAMA.
Scientific Stunt Double: How a Molecular Twin Is Changing Cancer Treatment, Research
When advanced technology and data from patients’ individual cells join forces, they can enormously expand what we know about cancer and how to treat it.
Improving Prostate Cancer Screening for Transgender Women
A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American Medical Association, concludes that current screening guidelines could miss early-stage prostate cancer in transgender women on hormone therapy.
Leo Mascarenhas, MD, MS, Continues Chairing Key Committee for Largest Research Organization Dedicated to Children With Cancer
Cedars-Sinai Cancer’s Blood and Marrow Transplant Patients Experience Superior Outcomes
Allogeneic transplants use blood stem cells from donors’ bone marrow to treat patients with blood and bone marrow diseases. The Cedars-Sinai team performs more than 40 such transplants each year.
A Clinic for Ovarian Cancer ‘Previvors’
Cedars-Sinai Cancer’s One-Stop Option Helps BRCA1- and BRCA2-Positive Patients Manage Fertility, Risk
Faculty Publications March 28-April 4
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published March 28-April 4.
Pediatric Cancer Expert Explains New Options for Children With Sarcomas
Q&A With Cedars-Sinai Guerin Children’s Pediatric Hematologist-Oncologist Leo Mascarenhas, MD, MS
Cedars-Sinai Cancer Releases 2024 Annual Report
The 2024 Cedars-Sinai Cancer Annual Report is now accessible. By harnessing the collective expertise of top cancer researchers and leveraging leading-edge Al technology, Cedars-Sinai Cancer is transforming cancer research and patient care ...
Upcoming CME
Newsroom: Cancer
There are no recent posts available.